Title |
Canine autoimmune hemolytic anemia: management challenges
|
---|---|
Published in |
Veterinary Medicine : Research and Reports, July 2016
|
DOI | 10.2147/vmrr.s81869 |
Pubmed ID | |
Authors |
James W Swann, Barbara J Skelly |
Abstract |
Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial. The main reason for this, as for most diseases in veterinary medicine, is the lack of large-scale placebo-controlled trials so that the efficacy of one treatment over another can be established. Most of the evidence used for treatment comes from retrospective studies and from personal preference and experience, and because of this, treatment regimens tend to vary among institutions and individual clinicians. Management of immune-mediated hemolytic anemia includes immunosuppression, thromboprophylaxis, and supportive care measures to help prevent and treat concurrent conditions. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 82 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 14 | 17% |
Other | 10 | 12% |
Student > Master | 10 | 12% |
Student > Doctoral Student | 5 | 6% |
Student > Postgraduate | 4 | 5% |
Other | 8 | 10% |
Unknown | 31 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Veterinary Science and Veterinary Medicine | 37 | 45% |
Unspecified | 3 | 4% |
Medicine and Dentistry | 3 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 2% |
Agricultural and Biological Sciences | 2 | 2% |
Other | 4 | 5% |
Unknown | 31 | 38% |